Want to join the conversation?
$EMN posted declining sales in three of its four segments during 2Q16. The largest decline was from Fibers segment, which dropped 22% YoverY. Sales from Chemical Intermediates segment fell 15% whereas from Additives & Functional Products fell 7%. Sales in Advanced Materials remained flat during the quarter.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?